Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton
Patents for C07C 229 - Compounds containing amino and carboxyl groups bound to the same carbon skeleton (21,416)
08/2010
08/18/2010CN101805342A Method for recycling urotropine and glycine in glycine-methanol mother liquor
08/18/2010CN101024618B Method for preparing aspartate
08/17/2010US7777073 Topical delivery system for antiaging and skin whitening agents
08/17/2010US7776309 Such as fluoromethyl-tyrosine and/or N,N-methyl-N-fluoromethylethanolamine
08/17/2010CA2450637C Solid-phase nucleophilic fluorination
08/17/2010CA2383814C Ultrafine l-carnitine, methods of preparing the same, compositions containing the same, and methods of using the same
08/17/2010CA2370412C Pharmaceutical compounds
08/12/2010WO2010090031A1 Method for producing optically active succinimide derivative and intermediate thereof
08/12/2010WO2010089512A1 Method for synthesizing an omega-amino acid or ester from a monounsaturated fatty acid or ester
08/12/2010WO2010089094A1 Process for the production of a fatty acid/l-carnitine derivative
08/12/2010WO2010070228A9 Process for the ammonolysis of 11-bromoundecanoic acid
08/12/2010US20100204505 Methods for producing phenylalanine derivatives having a quinazolinedione skeleton and intermediates for production thereof
08/12/2010US20100204480 Method for producing 4-aminobut-2-enolides
08/12/2010US20100204449 Methods and intermediates for chemical synthesis of polypeptides and proteins
08/12/2010US20100204271 Stable crystal of 4-oxoquinoline compound
08/12/2010US20100203637 Fluorescent cell markers
08/12/2010CA2747699A1 Method for synthesizing an omega-amino acid or ester from a monounsaturated fatty acid or ester
08/11/2010EP2216321A1 Process for the production of a fatty acid/carnitine derivative
08/11/2010EP2215050A2 Manufacturing method of 2-hydroxy-5-phenylalkylaminobenzoic acid derivatives and their salts
08/11/2010EP2215048A1 P2x3 receptor antagonists for treatment of pain
08/11/2010EP1654216B1 Process for the hydrogenation of aromatic compounds
08/11/2010EP1487763B1 Use of microfabricated devices for radiosynthesis
08/11/2010EP1484301B1 PROCESS FOR PRODUCING trans-4-AMINO-1-CYCLOHEXANECARBOXYLIC ACID DERIVATIVE
08/11/2010CN1990458B Process for preparing 4.4-difluoro-2-amino butyric acid with optical activity and ester thereof
08/11/2010CN101801917A Composition
08/11/2010CN101801916A branched polyesteramine acrylate
08/11/2010CN101801915A Process for the synthesis of na-beta-alaninate and calcium pantothenate
08/11/2010CN101801914A Process from shikimic acid to oseltamivir phosphate
08/11/2010CN101801913A Method for producing 4-aminobut-2-enolides
08/11/2010CN101798312A Novel route cefprozil compound
08/11/2010CN101798275A Method for preparing L-ornithine-L aspartate
08/11/2010CN101798274A Application of amphoteric surfactant in tertiary oil recovery, preparation method and application method of surfactant
08/11/2010CN101798273A Valine purification method
08/11/2010CN101139301B Method for preparing stability modified amido polycarboxylic acid ferric ammonium
08/10/2010US7772429 chemical intermediate 11-((4R,6R)-4,5,6-trihydroxy-3-(R)-hydroxy-2-(S)-hydroxyhexylcarbamoyl)undecanoic acid; for making antilipemic agents; anticholesterol agents
08/10/2010US7772428 Creatine hydroxycitric acids salts and methods for their production and use in individuals
08/10/2010US7772427 Uses for amino acid anticonvulsants
08/10/2010US7772425 Vitamin D receptor modulators
08/10/2010US7772280 adsorbing onto cation exchange resin, eluting with aqueous alkaline solution, mixing with hydrophilic organic solvent, and crystallizing
08/10/2010US7771723 Remedies for myeloma to be used together with nitrogen mustard antitumor agents
08/10/2010CA2451768C Peptoid compounds
08/10/2010CA2215827C O-malonyltyrosyl compounds, o-malonyltyrosyl compound-containing peptides, and uses thereof
08/05/2010WO2010086429A2 Intermediates in the enantioselective synthesis of 3-(aminomethyl)-5-methyl-hexanoic acid
08/05/2010US20100197953 Levodopa prodrugs, and compositions and uses thereof
08/05/2010US20100197928 Method for preparing disubstituted piperidine and intermediates
08/05/2010US20100197924 Preparation of aminotetralin compounds
08/05/2010US20100197841 Hydroxy acid amine salt, method for producing the same, and rubber composition containing the same
08/05/2010US20100197789 Anti-obesity agent and use thereof
08/05/2010US20100197787 Composition for Prevention of Hypoglycemic Condition
08/05/2010US20100197783 Radiation Protection Using Single Wall Carbon Nanotube Derivatives
08/05/2010US20100196922 Fluorescent metal ion indicators with large stokes shifts
08/04/2010EP2213659A1 Intermediates in the Enantioselective Synthesis of 3-(Aminomethyl)-5-Methyl-Hexanoic Acid
08/04/2010EP2213653A2 Method for the stereoselective preparation of amino acid derivatives
08/04/2010EP2212277A1 Amine linked modulators of y-secretase
08/04/2010CN101796015A Radiation curable compositions for food applications
08/04/2010CN101795733A tyrosinase inhibitors
08/04/2010CN101792399A Aminosalicylic acid derivative lysine complex salt, preparation method and application thereof
08/04/2010CN101792398A Method for preparing optical pure p-hydroxy phenyl glycine by separation method
08/04/2010CN101792397A Method for separating mixture of glycine and iminodiacetic acid by electrodialysis
08/04/2010CN101792396A Method for separating mixed glycine and iminodiacetic acid by utilizing nano-filtering technique
08/03/2010US7767847 Process for the preparation of chirally pure N-(trans-4-is)
08/03/2010US7767844 preparing a penta-alkyl DTPA (Diethylene Triamine Penta-acetic Acid) to be processed through regioselective hydrolysis with a metal ion as catalyst to obtain a tetra-alkyl DTPA, which is a monoreactive DTPA derivative, to be applied in related industries of imaging agents, medical services and chemistry
08/03/2010US7767811 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids
08/03/2010CA2204748C Use of dioxomorpholines for combating endoparasites, new dioxomorpholines and processes for their preparation
07/2010
07/29/2010WO2010085797A2 Arginase inhibitors and methods of use
07/29/2010WO2010084798A1 Tricyclic compound
07/29/2010WO2010084351A1 Chelating agents and methods relating thereto
07/29/2010WO2009153457A3 Novel compounds which have a protective activity with respect to the action of toxins and of viruses with an intracellular mode of action
07/29/2010US20100191012 Solid detergent composition
07/29/2010US20100190764 Novel compounds
07/29/2010CA2749853A1 Arginase inhibitors and methods of use
07/28/2010EP2209764A1 Gsm intermediates
07/28/2010EP2209390A1 Complex product with advanced assimilation efficacy for humans and its utilization
07/28/2010CN101786962A Method for producing amino acid chelate iron
07/28/2010CN101786961A Chromium threonine, preparation method and application thereof
07/28/2010CN101786960A Method for preparing betaine hydrochloride
07/28/2010CN101786952A Anthraquinone compound and preparation method and medical application of lysine salt thereof
07/28/2010CN101182297B Method for further reclamation of L-tyrosine from effluent of L-cystine production
07/28/2010CN101108815B Method of recycling precipitating agent in production of L-leueine
07/27/2010US7763752 such as 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentane-1-ol, used for treating autoimmune diseases, rheumatoid arthritis, psoriasis, dermatitis, asthma, hay fever or rejection of organ or bone morrow transplantation; side effect reduction
07/27/2010US7763654 wherein the diffraction pattern by powder X-ray diffractometry has characteristic peaks at diffraction angles (2 theta ) of 9.0, 13.6, 18.7, 20.6 and 24.8; has a beta 3-adrenaline receptor stimulating effect and is useful as an agent for treating pollakiuria or urinary incontinence
07/27/2010CA2424637C Selective binding materials
07/22/2010WO2010083215A2 Composition and method for the treatment of diseases affected by apoptosis
07/22/2010WO2009147141A3 Monoetherified diols of diamondoids
07/22/2010US20100184994 Method for Producing Difluoromethyl-Substituted Pyrazole Compounds
07/22/2010US20100184936 Diamine compound, polyamic acid, soluble polyimide, composition, wettability changing film, electrode, and method of manufacturing a wettability changing film
07/22/2010US20100184831 Materials and Complexes for the Delivery of Biologically-Active Materials to Cells
07/22/2010US20100184730 Fatty Acid Acylated Salicylates and Their Uses
07/22/2010US20100184709 Malt1 specific cleavage in assay and screening method
07/22/2010US20100184645 Stitched polypeptides
07/22/2010US20100184231 Method for the determination of an analyte comprising a primary amino group, and kit for labeling said analyte
07/22/2010US20100184054 Binding of pathological forms of prion proteins
07/22/2010US20100183580 Treatment of pigs for reducing the feed conversion ratio or increasing the growth rate
07/22/2010US20100183532 Performance-Boosting UV-Absorbing Compounds
07/21/2010CN101784513A Alkali metal salt of glutamic acid N,N-diacetic acid, a process to prepare such salt, and the use thereof
07/21/2010CN101781330A Propofol, phosphate and amino acid double salt and preparation method and application thereof
07/21/2010CN101781329A Propofol derivative for therapy
07/21/2010CN101781224A Cleaning production process of iminodiacetic acid
07/21/2010CN101781223A Method for catalytically synthesizing aminated compounds by using carbon-silicon solid acid as catalysts
07/20/2010US7759514 peptidomimetics such as (Z)-8-Amino-2-benzyl-3,7-dihydroxy-9-(4-hydroxy-phenyl)-non-4-enoic acid (1-carbamoyl-2-phenyl-ethyl)-amide, having improved selectivity to targets, improved bioavailability and lessened adverse side effects, used as analgesics
1 ... 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 ... 215